𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients

✍ Scribed by A. SWAMINATH; T. ULLMAN; M. ROSEN; L. MAYER; S. LICHTIGER; M. T. ABREU

Book ID
108605504
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
65 KB
Volume
29
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic review of postoperative compl
Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators
✍ V. Subramanian; R. C. G. Pollok; J.-Y. Kang; D. Kumar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Background This systematic review examined the use of immunomodulators and the risk of postoperative complications after abdominal surgery in patients with inflammatory bowel disease. ## Methods Electronic databases (PubMed, Embase, Ingenta, Zetoc and Ovid) were searched and the r

Incidence of nodular regenerative hyperp
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
✍ Philippe Seksik; Jean-Yves Mary; Laurent Beaugerie; Marc Lémann; Jean-Frederic C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

Background: Nodular regenerative hyperplasia (NRH) is a rare hepatic disorder that may lead to severe portal hypertension. Cases of NRH have been reported in patients receiving thiopurines for inflammatory bowel disease (IBD). Since azathioprine (AZA) is used more and more frequently as a maintenanc

Clinical usefulness of therapeutic drug
Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease
✍ Melissa L. Haines; Yousef Ajlouni; Peter M. Irving; Miles P. Sparrow; Rosemary R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Background: Circulating concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methyl mercaptopurine (6-MMP) are associated with thiopurine efficacy and may predict toxicity. This study aimed to examine retrospectively the utility of measuring metabolite concentrations in patients with inflammator